BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9017253)

  • 1. Protection against hypoxic-ischemic damage with corticosterone and dexamethasone: inhibition of effect by a glucocorticoid antagonist RU38486.
    Tuor UI; Del Bigio MR
    Brain Res; 1996 Dec; 743(1-2):258-62. PubMed ID: 9017253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and the prevention of hypoxic-ischemic brain damage.
    Tuor UI
    Neurosci Biobehav Rev; 1997 Mar; 21(2):175-9. PubMed ID: 9062940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro.
    Pickering WP; Baker FE; Brown J; Butler HL; Govindji S; Parsons JM; Pawluczyk IZ; Walls J; Bevington A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1475-84. PubMed ID: 12897084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning attenuates gastric ischemia-reperfusion injury through involvement of glucocorticoids.
    Bobryshev P; Bagaeva T; Filaretova L
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():155-60. PubMed ID: 20388959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hypoxic-ischemic damage with dexamethasone is dependent on age and not influenced by fasting.
    Tuor UI; Chumas PD; Del Bigio MR
    Exp Neurol; 1995 Mar; 132(1):116-22. PubMed ID: 7720820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats.
    Ohyama T; Sato M; Ohye H; Murao K; Niimi M; Takahara J
    Peptides; 1998; 19(6):1063-7. PubMed ID: 9700756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist.
    Konagaya M; Bernard PA; Max SR
    Endocrinology; 1986 Jul; 119(1):375-80. PubMed ID: 2424746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats.
    Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ
    J Endocrinol Invest; 1995 Dec; 18(11):833-9. PubMed ID: 8778154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone effects on cerebral protein synthesis prior to and following hypoxia-ischemia in immature rat.
    Tuor UI; Manley JJ; Fyfe C; Bascaramurty S
    Brain Res Bull; 1999 Jan; 48(1):61-4. PubMed ID: 10210168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of nonsteroidal antiinflammatory drug gastropathy by glucocorticoid deficiency or blockade of glucocorticoid receptors in rats.
    Filaretova L; Bagaeva T; Makara GB
    Life Sci; 2002 Oct; 71(21):2457-68. PubMed ID: 12270751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin-induced hypoxic-ischemic tolerance is mediated by up-regulation of corticosterone in neonatal rat.
    Ikeda T; Yang L; Ikenoue T; Mallard C; Hagberg H
    Pediatr Res; 2006 Jan; 59(1):56-60. PubMed ID: 16327010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PKCbeta improves glucocorticoid-induced insulin resistance in rat adipocytes.
    Kawai Y; Ishizuka T; Kajita K; Miura A; Ishizawa M; Natsume Y; Uno Y; Morita H; Yasuda K
    IUBMB Life; 2002 Dec; 54(6):365-70. PubMed ID: 12665248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486.
    Llovera M; García-Martínez C; Costelli P; Agell N; Carbó N; López-Soriano FJ; Argilés JM
    Cancer Lett; 1996 Jan; 99(1):7-14. PubMed ID: 8564931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Activation of Glucocorticoid Receptors in the Prefrontal Cortex Mediates the Expression of Contextual Conditioned Fear in Rats.
    Reis FM; Almada RC; Fogaça MV; Brandão ML
    Cereb Cortex; 2016 Jun; 26(6):2639-49. PubMed ID: 25976757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity.
    Mulholland PJ; Self RL; Harris BR; Littleton JM; Prendergast MA
    Neuroscience; 2004; 125(3):671-82. PubMed ID: 15099681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor mediated the propofol self-administration by dopamine D1 receptor in nucleus accumbens.
    Wu B; Liang Y; Dong Z; Chen Z; Zhang G; Lin W; Wang S; Wang B; Ge RS; Lian Q
    Neuroscience; 2016 Jul; 328():184-93. PubMed ID: 27126557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding.
    Spiga F; Knight DM; Droste SK; Conway-Campbell B; Kershaw Y; MacSweeney CP; Thomson FJ; Craighead M; Peeters BW; Lightman SL
    J Psychopharmacol; 2011 Feb; 25(2):211-21. PubMed ID: 20093322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucocorticoid receptor antagonist RU 38486 on acute glucocorticoid-induced insulin resistance in rat adipocytes.
    Ishizuka T; Nagashima T; Kajita K; Miura A; Yamamoto M; Itaya S; Kanoh Y; Ishizawa M; Murase H; Yasuda K
    Metabolism; 1997 Sep; 46(9):997-1002. PubMed ID: 9284886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.